Cure My Disease

Don't miss your cure!

 Log in / Sign up

Doctors to perform pain procedures at Patients' homes in new study

NCT ID NCT07265492

Symptom relief Sponsor: Hospital de Manises Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether doctors can safely perform ultrasound-guided pain procedures, like nerve blocks, at home for patients with chronic or cancer pain. It includes 100 adults already receiving home hospital care. The goal is to see if this approach reduces pain, cuts down on opioid use, and improves quality of life without needing a hospital visit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ultrasound-guided pain procedures (nerve blocks, infiltrations)
What this could lead to
If successful, this could offer a new way to manage severe pain at home, reducing the need for hospital trips and high-dose opioids.
What could go wrong
This is a small, early observational study (100 participants) testing feasibility. It may not prove effectiveness or be widely applicable, and procedures carry risks like infection or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2025

An estimate. Start dates often move.

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients admitted to the Home Hospitalization Unit (HHU) of the Manises Health Department who present with acute, chronic, oncologic, or complex pain requiring assessment for interventional pain management at home. The study population includes individuals with adequate clinical stability to undergo minimally invasive procedures in the domiciliary setting, as evaluated by a UDOPAL-trained physician. Patients may present a wide range of pain etiologies, functional limitations, or palliative needs commonly managed during home hospitalization.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥18 years old) admitted to the Home Hospitalization Unit (UHD) of the Manises Health Department. * Presence of active pain, classified as mild, moderate, or severe. * Clinical assessment indicating suitability for interventional pain management, as determined by a UDOPAL-trained physician. * Physical and clinical conditions that allow the performance of interventional procedures at home under standardized safety precautions. * Signed informed consent obtained from the patient and/or a legally authorized representative in cases of incapacity. Exclusion Criteria: * Very limited life expectancy (estimated survival \<72 hours) or terminal/agonal condition. * Contraindication to interventional pain procedures, including: 1. Uncorrectable coagulopathy. 2. Systemic infection or local infection at the puncture site. 3. Documented allergy to any of the planned medications. 4. Tumor located in the infiltration area. 5. Pregnancy or breastfeeding. * Altered level of consciousness or severe cognitive impairment without a responsible family member or without the possibility of obtaining valid informed consent. * Home environment conditions that do not ensure minimal hygiene, safety, or logistical support (e.g., inadequate lighting, lack of privacy, insufficient family assistance, or limited access for the medical team). * Explicit refusal by the patient and/or family to undergo interventional pain procedures. * Refusal to participate in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cancer Pain Chronic Pain chronic pain syndrome neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer pain Chronic pain Neuropathic pain Palliative care

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.